OCULAR THERAPEUTIX, INC 4
4 · OCULAR THERAPEUTIX, INC · Filed Jul 31, 2014
Insider Transaction Report
Form 4
Chadha Jaswinder
Director
Transactions
- Conversion
Common Stock
2014-07-30+92,570→ 130,448 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2014-07-30−100,000→ 0 total(indirect: See Footnote)→ Common Stock (37,878 underlying) - Conversion
Series B Preferred Stock
2014-07-30−27,144→ 0 total(indirect: See Footnote)→ Common Stock (10,282 underlying) - Conversion
Series C Preferred Stock
2014-07-30−117,243→ 0 total(indirect: See Footnote)→ Common Stock (44,410 underlying)
Footnotes (2)
- [F1]Each share of Series A, Series B and Series C Preferred Stock converted into Common Stock on a 2.64-for-one basis upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The preferred stock had no expiration date.
- [F2]The securities are directly held by the Jaswinder Chadha 2007 Delaware Trust. The Reporting Person is the beneficiary of the Jaswinder Chadha 2007 Delaware Trust.